The HCPLive Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for C difficile, IBS and IBD, Crohn's disease, and more.
April 22nd 2024
Announced on April 18, the approval is based on the VISIBLE 2 trial and comes less than 7 months after the approval of SC vedolizumab in ulcerative colitis.
Show Me the Data: Bridging Clinical Gaps in Later Lines of Metastatic CRC… It’s Easy as VEGFR1, 2, 3!
April 17, 2024
View More
9th Annual School of Gastrointestinal Oncology® (SOGO®)
View More
Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs
View More
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
Rapid Oncology Abstract Review®: Key Updates in Gastrointestinal Cancers from the ASCO Annual Meeting
View More
Medical Crossfire®: Bridging Precision Medicine Techniques and Emerging Treatments in Metastatic Colorectal Cancer
View More
Community Practice Connections™: 8th Annual School of Gastrointestinal Oncology®
View More
Burst CME: Incorporating the Latest Updates in IBS Treatment into Your Practice
View More
Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing
View More
Oncology Town Hall: Live Report from Barcelona for Advances in the Treatment of GI Cancers
View More
Cancer Summaries and Commentaries™: Clinical Updates in RCC from Chicago
View More
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
2024 Miami International Symposium of Gastrointestinal Oncology (ISGIO)
October 11-12, 2024
Register Now!
6th Annual Precision Medicine Symposium: An Illustrated Tumor Board
October 18-19, 2024
Register Now!
Community Practice Connections™: 20th Annual Meeting of the International Society of Gastrointestinal Oncology®
View More
Working Group: Streamlining the Pathway from Diagnosis to Treatment in Inflammatory Bowel Disease
View More
Advances In™: The Evolving Role of VEGFR in the Treatment of Refractory mCRC
View More
41st Annual CFS®: Innovative Cancer Therapy for Tomorrow
View More
Show Me the Data: Bridging Clinical Gaps in Later Lines of Metastatic CRC… It’s Easy as VEGFR1, 2, 3!
View More
The Next Wave in Biliary Tract Cancers: Leveraging Immunogenicity to Optimize Patient Outcomes in an Evolving Treatment Landscape
View More
Tissue Stewardship and the Evolving Role of Genomic Alterations in Providing Precision NSCLC Care
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Poor Sleep Connected to Obesity, Diabetes, and Heart Disease
January 30th 2012Poor sleep is connected to a significantly increased risk for major cardiovascular and metabolic disorders, such as obesity, diabetes, and coronary artery disease, researchers at the University of Pennsylvania's Perelman School of Medicine have found.
Tips to Avoid GERD Symptoms for Holiday Meals
December 19th 2011This holiday season, giant holiday meals will be the source of painful symptoms-such as heartburn-for the 45 million Americans living with acid reflux, including many who suffer from gastroesophageal reflux disease (GERD). Doctors across the nation, however, are striving to aid these sufferers by conveying some tips on how to avoid acid reflux issues this season.
Clinical Characteristics of Refractory GERD Patients Investigated
December 15th 2011A research group based in Israel has published results of a study investigating how the clinical characteristics of gastroesophageal reflux disease patients who respond to proton pump inhibitor therapy differ from those of patients who fail to respond.
GERD-induced Aspiration Appears to Increase Chances of Lung Transplant Failure
November 30th 2011There is strong evidence that GERD-induced aspiration helps to cause lung transplant failure, though more research is needed to identify the underlying pathogenic mechanism of injury to the transplanted organ, finds a recent review of studies on the topic.
Dr. Dhiraj Yadav on the Causes of Pancreatitis [Podcast]
November 28th 2011Dhiraj Yadav, MD, discusses the epidemiology of chronic pancreatitis, including his finding that less than half of cases are due to alcohol-related causes, the role of cigarette smoking in causing the disease, and challenges in diagnosing pancreatic exocrine insufficiency.
IBD Patients May Suffer Increased Skin Cancer Risk
November 22nd 2011According to two recently published studies, the risk of skin cancer may be increased in individuals who suffer from inflammatory bowel disease (IBD); the risk is heightened by the use of immunosuppressant medications, which typically are used to treat IBD. At this time, there are no recommendations for skin cancer screenings in IBD individuals.
47th Annual Gastroenterology Update: Rationale for Combination Therapy in Inflammatory Bowel Disease
November 18th 2011Dr. Jean-Paul Achker said there is room for improvement of response rates with current treatment approaches. "There may be a limited window of time to maximize anti-TNFα therapy, as evidenced by the observed loss of response over time, the need to increase the dose of anti-TNFα therapy, and immunogenicity," he said.
47th Annual Gastroenterology Update: Biologic Therapies for Inflammatory Bowel Disease, Part 2
November 17th 2011Ahmed Kandiel, MD, MPH, at the Cleveland Clinic concluded his lecture, "Which Patient/Which Biologic," by reviewing the results of a recently published meta-analysis which examined the risks and benefits of biologic therapy for patients with moderate-to-severe IBD.
47th Annual Gastroenterology Update: Biologic Therapies for Inflammatory Bowel Disease, Part 1
November 17th 2011Ahmed Kandiel, MD, MPH, kicked off the 47th Annual Gastroenterology Update with a thorough review of the current treatment landscape for moderate to severe inflammatory bowel disease, including the potential risks for side effects for each biologic agent.
Highlights from 47th Annual Gastroenterology Update at the Cleveland Clinic [Podcast]
November 17th 2011Bret Lashner, MD, MPH, FACG, shares his thoughts about the first day of the 47th Annual Gastroenterology Update at the Cleveland Clinic, including the recent developments with inflammatory bowel disease and hepatitis C therapy.
ACAAI 2011: Diverse Gut Bacteria in Infancy Protects for Life
The array of bacteria in the gut biome in the first six months of life provides protective benefits for the rest of life, according to Larry Borish, MD, FACAAI, professor of medicine at the University of Virginia.